We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
-12.33%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$2.42B
AUM Growth
-$643M
Cap. Flow
-$247M
Cap. Flow %
-10.23%
Top 10 Hldgs %
44.25%
Holding
312
New
77
Increased
20
Reduced
35
Closed
157

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$272M
2
JPM icon
JPMorgan Chase
JPM
+$102M
3
ET icon
Energy Transfer Partners
ET
+$88.1M
4
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$83.8M
5
EPD icon
Enterprise Products Partners
EPD
+$62M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$111M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$89.7M
3
AMLP icon
Alerian MLP ETF
AMLP
+$66.1M
4
PYPL icon
PayPal
PYPL
+$62.4M
5
COUP
Coupa Software Incorporated
COUP
+$54.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.79%
2 Technology 9.31%
3 Communication Services 6.91%
4 Consumer Staples 6.75%
5 Financials 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DEACW
126
DELISTED
Diamond Eagle Acquisition Corp. Warrant
DEACW
$953K 0.04%
333,333
– –
CNST
127
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$943K 0.04%
30,000
+5,000
+20% +$174K
TBPH icon
128
Theravance Biopharma
TBPH
$875M
$924K 0.04%
40,000
-10,000
-20% -$250K
GNLN icon
129
Greenlane Holdings
GNLN
$1.22M
– –
0
– –
SNAP icon
130
Snap
SNAP
$9.74B
$892K 0.04%
75,001
-1,224,999
-94% -$18.8M
LVGO
131
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$856K 0.04%
30,000
-20,000
-40% -$518K
CCJ icon
132
Cameco
CCJ
$40.5B
$853K 0.04%
+111,607
New +$915K
VTIQW
133
DELISTED
VectoIQ Acquisition Corp. Warrant
VTIQW
$776K 0.03%
398,100
-101,900
-20% -$151K
CTMX icon
134
CytomX Therapeutics
CTMX
$723M
$767K 0.03%
100,000
– –
IOVA icon
135
Iovance Biotherapeutics
IOVA
$1.95B
$748K 0.03%
25,000
-111,040
-82% -$2.94M
FATE icon
136
Fate Therapeutics
FATE
$300M
$535K 0.02%
+24,100
New +$609K
DMYT.U
137
DELISTED
dMY Technology Group, Inc. Units, each consisting of one share of Class A Common Stock and one-half
DMYT.U
$521K 0.02%
+53,000
New +$531K
NERV icon
138
Minerva Neurosciences
NERV
$188M
$452K 0.02%
9,375
– –
XERS icon
139
Xeris Biopharma Holdings
XERS
$1.41B
$341K 0.01%
175,000
+125,000
+250% +$538K
HYACW
140
DELISTED
Haymaker Acquisition Corp. II Warrant
HYACW
$295K 0.01%
250,000
– –
SCPE.WS
141
DELISTED
SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an
SCPE.WS
$287K 0.01%
300,000
– –
BYSI icon
142
BeyondSpring
BYSI
$40.7M
$256K 0.01%
+20,000
New +$307K
BTRSW
143
DELISTED
BTRS Holdings Inc. Warrants
BTRSW
$235K 0.01%
250,000
– –
SVRA icon
144
Savara
SVRA
$1.11B
$212K 0.01%
100,000
– –
TYME
145
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$165K 0.01%
150,000
– –
RMG.WS
146
DELISTED
RMG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stoc
RMG.WS
$145K 0.01%
233,333
– –
TWNKW
147
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
$114K ﹤0.01%
200,000
– –
GOEVW
148
DELISTED
Canoo Inc. Warrant
GOEVW
$105K ﹤0.01%
300,000
– –
ANDAR
149
DELISTED
Andina Acquisition Corp. III Right
ANDAR
$70K ﹤0.01%
400,000
– –
THWWW
150
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
$60K ﹤0.01%
400,000
– –
4 5
6
7 8

Similar funds

SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
FC
Freemont Capital Singapore $4.91B AUM 5.45% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return

Moore Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Moore Capital Management held 312 positions worth $2.42B, down 21% from $3.06B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Moore Capital Management withdrew a net $247M in Q1 2020, closing 157 positions and reducing 35 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $89.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 20% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Moore Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $267M.

  • Moore Capital Management's largest Q1 2020 buy was Vanguard Short-Term Corporate Bond ETF: 3,381,774 shares worth $267M.
  • Moore Capital Management added most to Microsoft in Q1 2020, an estimated $54.6M increase.
  • Moore Capital Management's biggest Q1 2020 reduction was Alibaba, cutting an estimated $111M.
  • Moore Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2020, selling an estimated $89.7M.
  • Moore Capital Management's ten largest holdings make up 44% of its $2.42B portfolio in Q1 2020.
  • Moore Capital Management opened 77 new positions and closed 157 in Q1 2020.
  • Moore Capital Management's portfolio value fell 21% quarter-over-quarter to $2.42B.

Based on Moore Capital Management's 13F filing for Q1 2020, filed 15 May 2020.